Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-26

Clinical Trial Update: Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Dupuytren Contracture evaluating Xiapex with PNF; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xiapex (collagenase clostridium histolyticum)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Dupuytren Contracture | Phase 4 | Status: COMPLETED